Sign Up Today and Learn More About Clinc Stock
Invest in or calculate the value of your shares in Clinc or other pre-IPO companies through EquityZen's platform.
Clinc Stock
Clinc is a conversational AI platform that enables enterprises to build "human-in-the-room" level, next-gen, virtual assistants.
About Clinc Stock
Founded
2015
Headquarters
Ann Arbor, MI, US
Total Funding
59.8M
Industries
Software, Data and Analytics, Science and Engineering
Clinc Press Mentions
Stay in the know about the latest news on Clinc
Finastra Integrates Clinc’s Conversational AI into its Digital Banking Platform
spr • Dec 02, 2022
Clinc's virtual assistant integrates with Finastra Fusion
finextra • Dec 01, 2022
Finastra and Clinc announce collaboration to boost digital engagement and reduce service agent workload
prnewswire • Nov 30, 2022
Dannemora Federal Credit Union partners with Clinc Artificial Intelligence to enhance member service.
bit • Sep 09, 2022
Glia and Clinc partner on customer experience for FIs
finextra • Dec 09, 2021
Clinc Management
Leadership team at Clinc
Founder & Managing Director
Andreas Sohns
Founder & CEO
Julien Arnold
Join now and verify your accreditation status to gain access to:
- Clinc current valuation
- Clinc stock price
- Available deals in Clinc and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Clinc Stock
How to invest in Clinc stock?
Accredited investors can buy pre-IPO stock in companies like Clinc through EquityZen funds. These investments are made available by existing Clinc shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Clinc stock?
Shareholders can sell their Clinc stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."